In reference to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY 23 with Senior Management of Mankind Pharma Limited ('the Company')' and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the presentation that would be placed in a Performance and Business update call for Q4FY23 & FY 23 scheduled on Wednesday, 31st May 2023 at 12 noon (IST). The presentation is also being uploaded on the website of the company i.e. www.mankindpharma.com.